Fabrication of nanowires and hierarchically porous materials through supercritical co2 assisted nebulization
US-2015367038-A1 · Dec 24, 2015 · US
US10434224B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10434224-B2 |
| Application number | US-201815862840-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 5, 2018 |
| Priority date | Sep 22, 2015 |
| Publication date | Oct 8, 2019 |
| Grant date | Oct 8, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A material that is less populated by biofilms than known materials and is well tolerated by the body is provided. The material is an element introducible into or attachable on a human or animal body and includes a glass and/or glass ceramic and/or ceramic material at least in some areas thereof, which inhibits the formation of biofilms and/or on which human or animal cells grow if the element is introduced into the human or animal body or attached thereto, wherein the glass and/or glass ceramic material comprises at least: SiO 2 in a range from 60 to 75 wt % and ZnO in a range from 1 to 7 wt %.
Opening claim text (preview).
What is claimed is: 1. A structural article, consisting of a unitary, monolithic material capable of inhibiting the formation of biofilms thereon when the structural article is in contact with a human or animal body, the material comprising a glass and/or glass ceramic and/or ceramic that comprises SiO 2 in a range from 60 to 75 wt %, R 2 O in a range from 5 to 20 wt %, RO in a range from 0 to 10 wt %, Al 2 O 3 in a range from 1 to 6 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 0 to 8 wt %, ZnO in a range from 1 to 7 wt %, and FeO in a range from 0 to 5 wt %, wherein R 2 O is an oxide or a combination of oxides selected from the group consisting of Li 2 O, Na 2 O, and K 2 O, and wherein RO is an oxide or a combination of oxides selected from the group consisting of MgO, CaO, BaO, SrO, and any combinations thereof. 2. The structural article as claimed in claim 1 , wherein the glass and/or glass ceramic and/or ceramic material comprises: SiO 2 in a range from 60 to 70 wt %, R 2 O in a range from 5 to 20 wt %, RO in a range from 0 to 10 wt %, Al 2 O 3 in a range from 1 to 5 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 0 to 8 wt %, ZnO in a range from 1 to 7 wt %, FeO in a range from 0 to 5 wt %, and Na 2 O in a range from 2 to 10 wt %, and/or K 2 O in a range from 3.5 to 10 wt %. 3. The structural article as claimed in claim 1 , wherein the glass and/or glass ceramic and/or ceramic material comprises: a content of Ag of less than 0.3 wt %; and/or a content of P 2 O 5 of less than 0.5 wt %; and/or a content of F of less than 1 wt %. 4. The structural article as claimed in claim 1 , wherein the structural article is configured to be introduced into the human or animal body. 5. The structural article as claimed in claim 1 , wherein the structural article is configured to be implanted into the human or animal body. 6. The structural article as claimed in claim 1 , wherein the structural article is configured to be attached to the human or animal body. 7. The structural article as claimed in claim 1 , wherein the structural article is selected from the group consisting of an implant, a casing feedthrough of an implant, a vascular support, a stent, a catheter, an artificial heart valve, a casing for a transponder, a casing for a defibrillator, a casing for a pacemaker, a lab-on-chip, and a contact lens. 8. The structural article of a material as claimed in claim 1 , wherein the material comprises SiO 2 in a range from 62 to 66 wt %, Al 2 O 3 in a range from 3.8 to 4.5 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 3.5 to 4.5 wt %, ZnO in a range from 5 to 7 wt %, FeO in a range from 0.001 to 0.005 wt %, Na 2 O in a range from 5.9 to 6.5 wt %, K 2 O in a range from 8.3 to 9.1 wt %, and SeO 2 in a range from 0 to 0.04 wt %. 9. A structural article consisting of a substrate capable of inhibiting the formation of biofilms thereon when introduced into or attached onto a human or animal body, wherein the substrate includes a material of a glass and/or glass ceramic and/or ceramic of: SiO 2 in a range from 60 to 75 wt %, R 2 O in a range from 5 to 20 wt %, RO in a range from 0 to 10 wt %, Al 2 O 3 in a range from 1 to 6 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 0 to 8 wt %, ZnO in a range from 1 to 7 wt %, and FeO in a range from 0 to 5 wt %, wherein R 2 O is an oxide or a combination of oxides selected from the group consisting of Li 2 O, Na 2 O, and K 2 O, and wherein RO is an oxide or a combination of oxides selected from the group consisting of MgO, CaO, BaO, SrO, and any combinations thereof. 10. The structural article as claimed in claim 9 , wherein the glass and/or glass ceramic and/or ceramic material comprises: SiO 2 in a range from 60 to 70 wt %, R 2 O in a range from 5 to 20 wt %, RO in a range from 0 to 10 wt %, Al 2 O 3 in a range from 1 to 5 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 0 to 8 wt %, ZnO in a range from 1 to 7 wt %, FeO in a range from 0 to 5 wt %, and Na 2 O in a range from 2 to 10 wt %, and/or K 2 O in a range from 3.5 to 10 wt %. 11. The structural article as claimed in claim 9 , wherein the glass and/or glass ceramic and/or ceramic material comprises: a content of Ag of less than 0.3 wt %; and/or a content of P 2 O 5 of less than 0.5 wt %; and/or a content of F of less than 1 wt %. 12. The structural article as claimed in claim 9 , wherein the structural article is configured to be introduced into the human or animal body. 13. The structural article as claimed in claim 9 , wherein the structural article is configured to be implanted into the human or animal body. 14. The structural article as claimed in claim 9 , wherein the structural article is configured to be attached to the human or animal body. 15. The structural article as claimed in claim 9 , wherein the structural article is selected from the group consisting of an implant, a casing feedthrough of an implant, a vascular support, a stent, a catheter, an artificial heart valve, a casing for a transponder, a casing for a defibrillator, a casing for a pacemaker, a lab-on-chip, and a contact lens. 16. The structural article of a material as claimed in claim 9 , wherein the material comprises SiO 2 in a range from 62 to 66 wt %, Al 2 O 3 in a range from 3.8 to 4.5 wt %, B 2 O 3 in a range from 0 to 10 wt %, TiO 2 in a range from 3.5 to 4.5 wt %, ZnO in a range from 5 to 7 wt %, FeO in a range from 0.001 to 0.005 wt %, Na 2 O in a range from 5.9 to 6.5 wt %, K 2 O in a range from 8.3 to 9.1 wt %, and SeO 2 in a range from 0 to 0.04 wt %.
Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title
Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title
containing zinc or zirconium · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)} · CPC title
containing zinc · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.